Journal

Scribeberry Berry extends the AI scribe into forms, referrals, intake and follow-up tasks. Examine approval boundaries, verified completion and the questions a clinic should ask be...

Healthcare AI expansion depends on local financing, clinical pathways, data access and regulation, not simply translating a successful US product.

Free clinical AI still has operating costs: compare advertising, enterprise contracts and paid education without confusing price with independence.

Clinicians will need deep medical knowledge, evidence appraisal, patient communication and practical skills for supervising AI-assisted work.

Clinical AI can compete on making decisions inspectable, but citations, confidence displays and audit logs need clearly bounded claims.

A five-stage editorial framework separates clinical reference, recommendations, drafts, bounded actions and coordinated workflows without treating more autonomy as better.

Clinical software may benefit from specialised models and ordinary rules, but model routing and handovers need their own evaluation.

Medical AI may concentrate at the platform level while leaving room for specialists that solve particular clinical, local or educational problems.

Clinical decision support can be strategically valuable, but its economics depend on the task, evidence, workflow and who captures the benefit.

Healthcare AI investment targets different layers of care, but funding, valuation and planned spending must not be confused with realised clinical or financial returns.

Choose a medical AI assessment body by verified scope, relevant expertise and the complete engagement, rather than unsupported rankings of price or speed.

Map the distinct roles of manufacturers, regulators, conformity assessors, clinical safety officers and NHS adopters before a clinical AI launch.